Oral phenytoin pharmacokinetics during omeprazole therapy.
1. In a double-blind crossover study 10 healthy males received either placebo or omeprazole (40 mg day-1) for 9 days, a single dose of phenytoin (300 mg) being taken on the seventh day. 2. Omeprazole significantly increased the area under the curve (0 to 72 h) of phenytoin (mean +/- s.e. mean) from 121.6 +/- 14.0 to 151.4 +/- 13.6 micrograms ml-1 h) (P less than 0.01). 3. The peak concentration, and apparent elimination half-life of phenytoin also tended to be increased though not significantly. 4. The omeprazole-phenytoin interaction observed may be clinically important because of the low therapeutic index associated with phenytoin.
Prichard
P J
PJ
Department of Therapeutics, University Hospital, Nottingham.
Walt
R P
RP
Kitchingman
G K
GK
Somerville
K W
KW
Langman
M J
MJ
Williams
J
J
Richens
A
A
D000284:Administration, Oral; D000328:Adult; D004347:Drug Interactions; D006207:Half-Life; D006801:Humans; D008297:Male; D009853:Omeprazole / Q000009:adverse effects* / Q000627:therapeutic use; D010672:Phenytoin / Q000493:pharmacokinetics*
D010672:Phenytoin; D009853:Omeprazole